Parabilis Medicines, Inc.(PBLS)

Biotechnology · Cambridge, MA

$28.86-0.67 (-2.27%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T20:42:40.036Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:42:40.036Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: N/A
Quote price: 28.86

FMP input reference: 66afd7ad6fe085f612ae866be6517f9e897c4fba6e73e474a8e5d595bf17d99d

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

PBLS Earnings Yield Metrics

EARNINGS YIELD

N/A

PBLS Competitors' Earnings Yield

PBLS

Parabilis Medicines, Inc.

Current

Market Cap

$3.36B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACAD

Acadia Pharmaceuticals Inc.

vs PBLS

Market Cap

$3.38B

Earnings Yield

11.25%

TTM Avg

8.17%

3Y Avg

6.43%

5Y Avg

6.43%

VKTX

Viking Therapeutics, Inc.

vs PBLS

Market Cap

$3.31B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDNA

CareDx, Inc

vs PBLS

Market Cap

$3.30B

Earnings Yield

3.25%

TTM Avg

5.71%

3Y Avg

6.07%

5Y Avg

6.07%

PLSE

Pulse Biosciences, Inc.

vs PBLS

Market Cap

$3.44B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELC

Celcuity Inc.

vs PBLS

Market Cap

$3.47B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IDYA

IDEAYA Biosciences, Inc.

vs PBLS

Market Cap

$3.48B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IRTC

iRhythm Technologies, Inc.

vs PBLS

Market Cap

$3.52B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XENE

Xenon Pharmaceuticals Inc.

vs PBLS

Market Cap

$3.54B

Earnings Yield

N/A

TTM Avg

3.23%

3Y Avg

3.30%

5Y Avg

3.30%

TARS

Tarsus Pharmaceuticals, Inc.

vs PBLS

Market Cap

$3.19B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Parabilis Medicines, Inc. (PBLS)	$3.36B	N/A	N/A	N/A	N/A
Acadia Pharmaceuticals Inc. (ACAD)vs ›	$3.38B	11.25%	8.17%	6.43%	6.43%
Viking Therapeutics, Inc. (VKTX)vs ›	$3.31B	N/A	N/A	N/A	N/A
CareDx, Inc (CDNA)vs ›	$3.30B	3.25%	5.71%	6.07%	6.07%
Pulse Biosciences, Inc. (PLSE)vs ›	$3.44B	N/A	N/A	N/A	N/A
Celcuity Inc. (CELC)vs ›	$3.47B	N/A	N/A	N/A	N/A
IDEAYA Biosciences, Inc. (IDYA)vs ›	$3.48B	N/A	N/A	N/A	N/A
iRhythm Technologies, Inc. (IRTC)vs ›	$3.52B	N/A	N/A	N/A	N/A
Xenon Pharmaceuticals Inc. (XENE)vs ›	$3.54B	N/A	3.23%	3.30%	3.30%
Tarsus Pharmaceuticals, Inc. (TARS)vs ›	$3.19B	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

PBLS Earnings Yield Metrics

PBLS Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics